Epoxy stearic acid, an oxidative product derived from oleic acid

Subscriber access provided by Kaohsiung Medical University

Food Safety and Toxicology

Epoxy stearic acid, an oxidative product derived from oleic acid, induces cytotoxicity, oxidative stress and apoptosis in HepG2 cells Ying Liu, Yajun Cheng, Jinwei Li, Yuanpeng Wang, and Yuanfa Liu J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.8b01954 • Publication Date (Web): 06 May 2018 Downloaded from http://pubs.acs.org on May 6, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 34

Journal of Agricultural and Food Chemistry

1

Epoxy stearic acid, an oxidative product derived from oleic acid, induces

2

cytotoxicity, oxidative stress and apoptosis in HepG2 cells

3

Ying Liu, Yajun Cheng, Jinwei Li, Yuanpeng Wang, Yuanfa Liu*

4

School of Food Science and Technology, Synergetic Innovation Center of Food

5

Safety and Nutrition, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu

6

Province 214122, People’s Republic of China

7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

*Corresponding author: Yuanfa Liu

26

Phone: 0510-85876799; Fax: 0510-85876799; E-mail: [email protected]

1

ACS Paragon Plus Environment


27

ABSTRACT: In the present study, effects of cis-9,10-epoxy stearic acid (ESA)

28

generated by the thermal oxidation of oleic acid on HepG2 cells including

29

cytotoxicity, apoptosis and oxidative stress were investigated. Our results revealed

30

that ESA decreased the cell viability and induced cell death. Cell cycle analysis with

31

propidium iodide staining showed that ESA induced cell cycle arrest at the G0/G1

32

phase in HepG2 cells. Cell apoptosis analysis with annexin V and propidium iodide

33

staining demonstrated that ESA induced HepG2 cell apoptotic events in a dose- and

34

time-dependent manner, the apoptosis of cells after treated with 500 µM of ESA for

35

12 h, 24 h and 48 h was 32.16%, 38.70% and 65.80%, respectively. Furthermore,

36

ESA-treatment to HepG2 cells resulted in an increase in ROS and MDA (from 0.84

37

±0.02 nmol/mg protein to 8.90±0.50 nmol/mg protein) levels and a reduction in

38

antioxidant enzyme activity including SOD (from 1.34±0.27 U/mg protein to

39

0.10±0.007 U/mg protein), CAT (from 100.04±5.05 U/mg protein to 20.09±3.00

40

U/mg protein) and GSH-Px (from 120.44±7.62 mU/mg protein to 35.84±5.99

41

mU/mg protein). These findings provide critical information on the effects of ESA

42

on HepG2 cells, particularly cytotoxicity and oxidative stress, which is important for

43

the evaluation of the biosafety of oxidative product of oleic acid.

44

KEYWORDS: cis-9,10-epoxy stearic acid, HepG2 cell, cytotoxicity, apoptosis,

45

oxidative stress

46

2


Page 2 of 34

Page 3 of 34


47

INTRODUCTION

48

Lipid oxidation is a main cause of quality deterioration in lipid- and oil-containing

49

foods. Lipid oxidation involves a wide variety of reactions including degradation,

50

hydrolysis, polymerization and so on, which not only gives rise to nutrient loss and

51

off-flavor generation but also causes formation of potentially toxic compounds, and

52

thus decreases the product quality, sometimes even makes foods unsuitable for

53

consumption.1-5 Meanwhile, oxidized products including triacylglycerol (TAG)

54

polymers, TAG dimers, oxidized TAG monomers, diacylglycerols and free fatty

55

acids are formed. Among them, epoxy groups linked to TAG molecules, one of

56

oxidized TAG monomers have the highest content and are easily absorbed by both

57

animals and humans.6-8 In general, epoxy fatty acids are produced by the reaction of

58

corresponding fatty acids and the hydroperoxides9 and exert some adverse effects on

59

health.10-12

60

Cis-9,10-epoxystearic acid (ESA) was derived from thermal oxidation of oleic

61

acid and has been widely found in many food matrices.13-15 Recently, our research

62

group found ESA in frying oil and established an extraction method for ESA, and the

63

content of ESA in frying oil samples reached up to 5900 mg/kg.16 In addition, based

64

on the electron spin resonance spectroscopy method, the formation process of ESA

65

may be that oleic acid loses hydrogen radicals to form alkyl radicals which could

66

react with oxygen to form hydroperoxides, then the O-O bonds of hydroperoxides

67

break to form alkoxyl radicals which could abstract hydrogen from other oleic acids

68

to form ESA (Figure 1). Most of the research relevant to epoxy fatty acids focused 3



Page 4 of 34

69

on epoxy oleic acids. Fukushima et al.10 found 9,10-epoxy-12-octadecenoate could

70

increase

71

9,10-epoxy-12-octadecenoate induced pulmonary edema in rats. However, the effect

72

of ESA derived from OA on animals or cells remains largely unknown.

the

risk

of

cardiovascular

diseases.

Hu

et

al.17

found

73

The HepG2 cell line which was selected because of its comparability to the

74

normal hepatocytes in aspects of expression of specific enzymes and the enzyme

75

activities,18-20 has been widely used as the human hepatoma model in the

76

performance of lipid metabolic process.21-23 The present study investigated the effect

77

of ESA formed by thermal oxidation of OA on HepG2 human hepatoma cells by

78

considering cell viability, cytotoxicity, apoptosis, intracellular ROS level, activities

79

of antioxidant enzymes and lipid peroxide level in order to explore cytotoxicity and

80

oxidative stress of ESA, which is important for evaluating the biosafety of oxidative

81

product of oleic acid.

82

MATERIALS AND METHODS

83

Chemicals. Cis-9,10-epoxystearic acid (99% purity) was purchased from Toronto

84

Research Chemicals (Toronto, Canada). OA and dimethyl sulfoxide (DMSO) were

85

purchased from J & K Chemical Technology (Shanghai, China). HepG-2 cells were

86

purchased from the Institute of Biochemistry and Cell Biology, SIBS, CAS

87

(Shanghai, China). Minimum Essential Medium (MEM) was obtained from

88

Shanghai BasalMedia Technologies Co., LTD (Shanghai, China). MTT was

89

purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Trypsin, fetal bovine

90

serum (FBS), and other cell culture materials were purchased from Gibco BRL, Life 4


Page 5 of 34


91

Technologies

(USA).

The

Reactive

Oxygen

Species

(ROS)

Assay

Kit,

92

Malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) and

93

glutathione peroxidase (GSH-Px) assay kits were all purchased from Beyotime

94

Biotechnology Co. Ltd (Shanghai, China). The Annexin V-FITC Apoptosis

95

Detection Kit, Cell Cycle Analysis Kit were also obtained from Beyotime

96

Biotechnology Co. Ltd (Shanghai, China). All chemicals and reagents were of

97

analytical grade or higher.

98

Cell culture and treatment. HepG2 human hepatocellular carcinoma cells were

99

cultured in MEM medium containing 10% FBS, 100 U/mL penicillin and 75 U/mL

100

streptomycin (Gibco BRL, Life Technologies, USA). Cells were incubated at 37 °C

101

with 5% CO2 in humidified atmosphere. HepG2 cells were treated with OA and ESA

102

at various concentrations (10, 20, 50, 100, 200 and 500 µM) for 12, 24 and 48 h.

103

Cytotoxicity measurements by MTT assay. Undifferentiated HepG2 cells were

104

plated into a 96-well plate (5 × 104 cells per mL) and preincubated for 24 h to

105

ascertain cell attachment at 37 °C. The viability of cells was determined by the MTT

106

assay. HepG2 cells were treated with fatty acids at various concentrations for

107

different time. Following treatment, 10 µL MTT (5 mg/mL) reagent was added to the

108

wells, and the cells were further incubated at 37 °C for 4 h. And then the medium

109

was replaced with 150 µL DMSO and incubated for 15 min. The absorbance was

110

measured at 490 nm using a microplate reader (Thermo, USA). The cell viability (%)

111

was calculated using the following equation:

112

Cell viability (%) = Atreated/Acontrol × 100% 5



113

Cell cycle analysis. Cell cycle analysis was conducted using the Cell Cycle

114

Analysis Kit (Beyotime, Shanghai, China), according to the manufacturer’s

115

instructions. Briefly, HepG2 cells (1 × 106 cells/well) were seeded in six-well plates

116

and treated with fatty acids at various concentrations for different time. Then the

117

cells were harvested, washed with ice-cold PBS buffer and fixed with 70% alcohol at

118

4 °C for 12 h. After that, DNA was stained with 10 µL propidium iodide (PI; 1

119

mg/ml) and 10 µL RNase A (10 mg/ml) for 30 min at room temperature. Cells were

120

then subjected to flow cytometry (BD FACSCalibur, San Jose, CA, USA). The

121

percentage of cells in G1, S, and G2 phases of the cell cycle was calculated using

122

Cell Lab Quanta SC software (Beckman Coulter Inc, Fullerton, CA).

123

Cell apoptosis analysis. Cell apoptosis was detected with an Annexin V-FITC

124

Apoptosis Detection Kit (Beyotime, Shanghai, China) according to the

125

manufacturer’s instructions. Briefly, HepG2 cells (1 × 106 cells/well) were seeded in

126

six-well plates and treated with fatty acids at various concentrations for different

127

time. Cells were then collected, washed with annexin-binding buffer, and stained

128

with annexin V-fluorescein isothiocyanate (FITC) and PI for 15 min at room

129

temperature. Finally, cells were analyzed by flow cytometry (BD FACSCalibur, San

130

Jose, CA, USA).

131

Measurement of ROS. The level of ROS was determined by measuring changes

132

in 20, 70-dichlorofluorescein diacetate (DCFH-DA) fluorescence. After treated with

133

fatty acids, cells were incubated with DCFH-DA according to manufacturer’s

134

instructions. Subsequently, the formation of the fluorescent-oxidized derivative of 6


Page 6 of 34

Page 7 of 34


135

DCF was measured by flow cytometer (BD FACSCalibur, San Jose, CA, USA) at

136

emission wavelength of 525 nm and excitation wavelength of 488 nm.

137

Measurements of SOD, GSH-Px, CAT and MDA. The assay for superoxide

138

dismutase (SOD),

glutathione

139

malondialdehyde (MDA) was carried out using commercial assay kits. Briefly, the

140

SOD activity was measured using its ability to inhibit the reduction of WST-8

141

according to the manufacturer’s instructions. SOD activity was monitored

142

spectrophotometrically at 450 nm using a microplate reader (Thermo, USA).

143

GSH-Px was detected by measuring the decreasing amount of NADPH and

144

monitored at 340 nm according to the instructions of kit. CAT was detected by

145

measuring

146

(N-(4-antipyryl)-3-chloro-5-sulfonate-p-benzoquinonemonoimine)

147

hydrogen peroxide and oxygen at 520 nm. The content of MDA was determined by

148

measuring the absorbance of MDA-TBA reacted by MDA and TBA at 532 nm.

the

peroxidase

absorbance

(GSH-Px), catalase (CAT) and

of

red

compound reacted

by

149

Statistical analysis. Analytical determinations were performed in triplicate and

150

the results were expressed as mean ± standard deviation of replicated measurements.

151

Statistical comparisons were performed by one-way ANOVA combined with

152

Duncan’s multiple-range test using the SPSS statistical package (Version 19.0, SPSS

153

Inc., Chicago, Illinois, USA). P < 0.05 was considered significant.

154

RESULTS

155

Effects of OA and ESA on HepG2 cell viability. Effects of OA and ESA on the

156

viability of HepG2 cells are shown in Figure 2. The MTT assay demonstrated a 7



157

gradual decrease in HepG2 cell viability with the increasing concentrations of fatty

158

acids treated for 12-48 h. At the lower treatment dose (10-50 µM) of OA, the

159

viability of cells was kept above 70%. When HepG2 cells were exposed to OA with

160

concentration of 100-500 µM, the cell viability slightly decreased and maintained at

161

a certain level ranging from 57-67%. Compared to OA, ESA significantly inhibited

162

cell viability, and cell viability decreased with the increasing concentration and time

163

of ESA treatment. ESA treatment at 10-20 µM for 12, 24 and 48 h caused a 65-71%,

164

51-56% and 50-52% loss in cell viability, respectively. While after treatment of 500

165

µM ESA for 12, 24 and 48h, the number of the alive cells decreased, with cell

166

viability values of 30.01%, 25.69% and 24.41%, respectively. The maximum

167

inhibition (75.59%) was observed in cells treated with 500 µM ESA for 48 h. Based

168

on these results, it was clear that ESA caused a dose- and time-dependent decrease in

169

HepG2 cell viability.

170

Effects of OA and ESA on cell cycle arrest in HepG2 cells. To investigate

171

whether OA and ESA could induce cell cycle distribution in HepG2 cells, flow

172

cytometric analysis of propidium iodide-stained nuclei cells was performed after

173

treatment with OA and ESA at various concentrations (10-500 µM) for 12-48 h. As

174

shown in Figure 3A, results revealed that HepG2 cells treated with OA presented

175

with a dose- and time-dependent increase in the cell population of G0/G1 phase.

176

Meanwhile, the proportion of cells in S phase decreased. A similar concentration-

177

and time-related increase in the fraction of cells in the G0/G1 phase and decrease in

178

the fraction of cells in the S phase was observed in ESA-treated groups (Figure 3B). 8


Page 8 of 34

Page 9 of 34


179

As shown in Figure 3, untreated cells had 51.39%, 57.61% and 59.51% of cells in

180

G0/G1 phase and 41.90%, 35.10% and 33.94% of cells in S phase after 12 h, 24 h

181

and 48 h, respectively. However, 60.50%, 66.94% and 67.02% of cells in G0/G1

182

phase and 29.69%, 30.62% and 30.98% of those in S phase were detected when

183

HepG2 cells were exposed to 500 µM OA for 12 h, 24 h and 48 h, respectively. In

184

particular, when the concentrations of ESA reached 500 µM, the fraction of cells in

185

the G0/G1 phase increased dramatically (68.34%, 78.11% and 82.83%, compared to

186

351.39%, 57.61% and 59.51% in untreated cells), which suggested that HepG2 cells

187

underwent DNA fractionation, one of the biochemical events leading to apoptosis.

188

Taken together, these results indicated that ESA could inhibit HepG2 cell

189

proliferation significantly by blocking the G0/G1 to S phase transition in the cell

190

cycle in a dose- and time-dependent manner.

191

Effects of OA and ESA on apoptosis in HepG2 cells. In the present work,

192

combined analysis of Annexin V-FITC and PI based on flow cytometry was carried

193

out to determinate the apoptotic rate of HepG2 cells induced by OA and ESA. In

194

Figure 4, cells in the Q2 are described as advanced apoptotic or necrotic, normal

195

cells are seen in the Q3 and cells in the Q4 are classified as early apoptotic. As

196

shown in Figure 4, the cell apoptosis of HepG2 increased slowly by treated with

197

different concentration of OA for 12 h and 24 h. In terms of ESA, increasing

198

concentrations of ESA for 12-h treatment induced apoptotic events, especially early

199

apoptosis, in a dose-dependent manner. While the percentage of late apoptosis and

200

dead cells increased with the increased concentration of ESA for 24-h treatment. At 9



201

500 µM of ESA for 12-h and 24-h treatment, the apoptosis was 32.16% and 38.70%,

202

respectively. They were more than 8 and 6 times of that in control group,

203

respectively. As the concentration of ESA increased, the apoptotic rate of the HepG2

204

cells elevated dramatically (P < 0.05). Specially, compared with the control group,

205

HepG2 cells treated with 500 µM OA and ESA for 48 h increased the apoptosis rate

206

from 15.51% to 56.10% and 65.80% apoptosis, respectively. Interestingly, after

207

treating HepG2 with 200-500 µM OA for 48 h, the apoptosis rate was above 40%,

208

one possible reason may be that HepG2 cells occurred cell death after long-time

209

OA-treatment and nutrient deficiency. These results suggested that ESA could induce

210

dramatic apoptosis in HepG2 cells.

211

Effect of OA and ESA on ROS accumulation in HepG2 cells. DCF

212

fluorescence was used to measure the level of ROS that was induced by OA and

213

ESA exposure. As shown in Figure 5, compared with the control group, the

214

intracellular ROS level in HepG2 cells after different concentrations of

215

OA-treatment for 12 h and 24 h showed a gradual and slight increase in a dose- and

216

time-dependent manner. A significant increase in ROS generation was observed over

217

time ranging from 12-24 h in the cells treated with different concentration of ESA (P

218

< 0.05). After HepG2 cells were treated with 500 µM ESA for 12 h and 24 h, cellular

219

fluorescence intensity were 2.6-fold and 3.0-fold of the non-ESA-treated control

220

HepG2 cells. However, in contrast to HepG2 cells treated for 12 h and 24 h, although

221

intracellular ROS level increased after OA and ESA exposure for 48 h, it maintained

222

at relatively low level after 48 h exposure to all concentrations of OA and ESA. 10


Page 10 of 34

Page 11 of 34


223

Leakage of probe was not observed in cells in pre-tests. Therefore, the final

224

fluorescence caused by extracellularly oxidized DCF could be excluded. The reason

225

for this may be long-time OA- and ESA-treatment and nutrient deficiency led to a

226

high percentage of cell death, the level of intracellular ROS therefore relatively low.

227

Our results indicated that ESA treatment could induce abnormal accumulation of

228

intracellular ROS in HepG2 cells.

229

Effects of OA and ESA on the activities of antioxidant enzymes and lipid

230

peroxide levels in HepG2 cells. As ESA might induce accumulation of intracellular

231

ROS and lead to oxidative damage to HepG2 cells, MDA, a product of lipid

232

peroxides induced by reactive oxygen species, was also measured in HepG2 cells. As

233

can be seen in Figure 6A, treatment for 12-48 h with different concentrations of OA

234

could only slightly increase the content of MDA in HepG2 cells, indicating a

235

relatively low level of lipid peroxidation in response to OA-treatment in cells. The

236

increase concentration of MDA in HepG2 cells treated with ESA was found to be

237

dose- and time-dependent. Meanwhile, statistically significant increase in MDA

238

levels was observed after ESA-treatments for 12-24 h in cells when compared with

239

the control group. Interestingly, after cells with OA-treatment for 48 h, levels of

240

MDA showed a trend to be almost similar to those of control untreated cells, even

241

after 48 h with 500 µM. Although the 48-h treatment of HepG2 with ESA evoked an

242

increase in the cellular concentration of MDA, the levels of intracellular MDA were

243

much lower than those treated for 12 h and 24 h. This could be attributed to the lack

244

of nutrients and long-time treatment, which was in line with the results of 11



245

intracellular ROS levels.

246

Cellular damage caused by ROS depends not only on the intracellular ROS level

247

but also on the balance between ROS and endogenous antioxidant species. The

248

intracellular SOD, a biomarker for antioxidative status in the cell, was detected in

249

HepG2 cells treated with OA and ESA. Results demonstrated that the SOD content

250

decreased with the increasing concentration and time of OA- and ESA-treatment

251

(Figure 6B). Treatment for 12-24 h with different concentrations of OA only slightly

252

decreased the content of SOD in HepG2 cells. While SOD levels in ESA-treatment

253

groups decreased rapidly (P < 0.05), the activity of SOD in cells that were exposed

254

to ESA at 500 µM for 12 h, 24 h and 48 h were reduced by 51.37%, 69.95% and

255

84.64%, respectively, when compared to the control group.

256

Furthermore, decreased activity of CAT in HepG2 cells treated with OA and ESA

257

was also observed (Figure 6C). The activity of CAT in cells treated with different

258

concentrations of OA for 12 h and 24 h induced a slight decrease when compared to

259

the control group from 100.04 U/mg pro and 92.49 U/mg pro to 82.62 U/mg and

260

81.29 U/mg, respectively. However, a significant decrease (P < 0.05) in CAT levels

261

were shown after ESA-treatments for 12 h and 24 h in HepG2 cells, at 500 µM of

262

ESA for 12-h and 24-h treatment, the activity of CAT in cells were reduced by 32.72%

263

and 58.34%, respectively. Specially, in contrast to HepG2 cells treated for 12 h and

264

24 h, intracellular CAT activity decreased dramatically (P < 0.05) after OA and ESA

265

exposure for 48 h.

266

GSH-Px could catalyze the reduction of lipid hydroperoxides to hydroxides using 12


Page 12 of 34

Page 13 of 34


267

GSH, in which oxidized glutathione is produced by GSH and then be reduced back

268

to GSH with the GR catalyst. As shown in Figure 6D, a reduction in the levels of

269

GSH-Px was detected in HepG2 cells after treatment with OA and ESA, as

270

compared to the control group. Specially, ESA treatment significantly reduced

271

GSH-Px levels in a dose- and time-dependent manner. The presence of 500 µM ESA

272

in the culture medium for 12 h and 24 h induced a significant decrease in the activity

273

of GSH-Px compared with control group from 120.44 mU/mg pro and 113.32

274

mU/mg pro to 61.09 mU/mg pro and 50.73 mU/mg pro, respectively. Furthermore,

275

after pretreatment of cells with different concentrations of OA and ESA for 48 h,

276

levels of GSH-Px showed a trend to be far below those of cells treated with OA and

277

ESA for 12 h and 24 h.

278

The increase in the MDA content and decrease in the SOD, CAT and GSH-Px

279

activities of cells demonstrated that exposure to ESA induced oxidative stress, and

280

cells treated with ESA may lose the ability to maintain the balance between ROS and

281

antioxidants.

282

DISCUSSION

283

Lipid oxidation products have been claimed to exert adverse effects on health in vivo

284

and vitro studies,5,24-27 including rising risks of nonalcoholic fatty liver disease,

285

atherosclerosis and diabetes mellitus. Moreover, cytotoxicity and oxidative stress

286

have been observed in subjects after the intake of oxidative products of lipid.28-31

287

However, the adverse effects of ESA produced from oxidized oleic acid remain

288

unknown. In the present study, the effects of ESA on cytotoxicity and oxidative 13



289

Page 14 of 34

stress of HepG2 cells were investigated.

290

Our results showed that cell viability, as determined by the MTT assay reduced

291

remarkably in a dose- and time-dependent manner after HepG2 cells were exposed

292

to ESA. The relatively little effect of OA on HepG2 cell survival rate was also

293

observed. This was consistent with the studies reported by Greene et al.32 and Cao et

294

al.33 in which epoxy fatty acids and triacylglycerol polymer (both derived from lipid

295

oxidation process) were used, respectively. In addition, cell cycle analysis were

296

carried out to illustrate ESA-induced cell cycle arrest. Results showed that the

297

percentage of cells in G0/G1 phase increased and those in S phase decreased in

298

HepG2 cells exposed to ESA, indicating that the inhibition of ESA on HepG2 cells

299

mainly occurred in G0/G1 phase. The apoptotic effect of ESA on HepG2 cells was

300

confirm by Annexin V-FITC/PI assay. Results indicated ESA-treatment for 12 h and

301

24 h mainly induced early apoptosis and late apoptosis in HepG2 cells based on a

302

dose-dependent manner, respectively. This finding was in agreement with other

303

studies, where the ingestion of oxidized products, containing polar compounds,

304

oxidized phospholipids, triacylglycerol polymer and auto-oxidation products from

305

cholesterol, inhibited cell proliferation and induced apoptosis compared to those

306

untreated cells.28,32-34

307

Further study found that the intracellular ROS levels in HepG2 cells were

308

markedly elevated after ESA-treatment, suggesting that ESA-induced cell damage

309

may

310

9,10-epoxy-12-octadecenoate on rats was observed by Ozawa et al.35 Ozawa and

be

related

to

excessive

ROS

production.

14


A

similar

effect

of

Page 15 of 34


311

co-workers found that 9,10-epoxy-12-octadecenoate, which is biosynthesized by

312

human neutrophil, led to stress response in lung. These results strongly suggested

313

that epoxy fatty acids could induce excessive generation of the intracellular ROS

314

level. It has been reported that ROS could perform normal functions when the

315

generation and elimination of ROS in normal cell systems is in equilibrium which

316

was maintained by the endogenous antioxidant system.33,36 However, excessive

317

accumulation of ROS causes injury to cellular components including nucleic acids,

318

cellular proteins and lipids, and activates cell apoptosis signaling pathways, leading

319

to a state known as oxidative stress.37 Moreover, oxidative stress is related to the

320

etiopathogenesis of several human chronic diseases such as many cardiovascular

321

diseases, aging, neurodegenerative diseases, diabetes and cancer.38-40

322

An elevated intracellular MDA level suggested that lipid peroxidation

323

significantly increased in HepG2 cells after ESA-treatment with the increase of ESA

324

concentration and exposure time. MDA which is the principal and most studied lipid

325

oxidation product of polyunsaturated fatty acid has been widely analyzed to assess

326

the level of oxidative stress. It has been reported that an increase in MDA value

327

indicated increased lipid peroxidation, which results in tissue injury and the failure

328

of antioxidant defense mechanisms for preventing excess ROS formation.41,42

329

Therefore, our results implied damage to the antioxidant defense system in cells. A

330

reduction of SOD activity, one of major components of the antioxidant capacity to

331

defense against ROS-mediated injury in tissue,43 was found in cells treated with ESA

332

compared to control group, indicating generation of oxidative stress was 15



333

accompanied by the reduced enzymatic antioxidant activity in HepG2 cells, which

334

was in accordance with the results reported by Bhor and colleagues,44 in which

335

intestinal oxidative stress occurred with a reduction of enzymatic antioxidant activity

336

in enterocytes. Moreover, a decrease in the CAT activity was seen in the HepG2 cells

337

pretreated with ESA. Similar results has been reported in previous studies with the

338

consumption of lipid oxidation products, in which the activities of SOD and CAT in

339

the liver were both significantly lowered.29 Catalase, an enzyme to catalyse the

340

oxidation of various hydrogen donors, could decompose hydrogen peroxide to

341

molecular oxygen and water. And reduced CAT activity in tissue causes oxygen

342

intolerance and triggers some deleterious reactions, especially DNA oxidation and

343

cell death.45 The GSH-Px activity, an essential antioxidant for the intracellular

344

quenching of cell damaging peroxide species, significantly decreased in cells treated

345

with ESA as compared to the control group. It is well known that the cellular

346

antioxidant enzyme system plays an important role in the defense against oxidative

347

stress, and the activity of antioxidant enzymes could be a biomarker of the

348

antioxidant response. Therefore, our results clearly demonstrated that ESA could

349

reduce the antioxidative capacity and induce oxidative stress in HepG2 cells, which

350

may aggravate the imbalance between oxidation and antioxidant in cells.

351

In conclusion, this is the first time to investigate the effect of ESA on the cytotoxic

352

and oxidative stress of human liver carcinoma cells. The current study clearly

353

demonstrated that administration of ESA to HepG2 cells for 12-48 h could induce

354

cytotoxicity, DNA damage, apoptosis and oxidative stress. ROS may play an 16


Page 16 of 34

Page 17 of 34


355

essential role in DNA damage and oxidative stress induced by ESA in vitro. Our

356

results showed that ESA treatment induced apoptosis activity on HepG2 cells

357

including cell proliferation, apoptosis and possible genetic damage, and

358

accumulation of ROS level. In addition, ESA also enhanced the lipid peroxides and

359

caused the decrease of enzyme activities of SOD, CAT and GSH-Px which were

360

biomarkers of cellular oxidative status. Further studies should be carried out to

361

investigate the pathological mechanism of ESA derived from thermal oxidized oleic

362

acid on apoptosis and oxidative stress of HepG2 cells.

363

AUTHOR INFORMATION

364

Corresponding Author

365

*

366

[email protected] (Y. L.).

367

ORCID

368

Yuanfa Liu: 0000-0002-8259-8426

369

Funding

370

This work was supported by the Natural Science Foundation of China (31671786),

371

the Research Fund of National 13th Five-Year Plan of China (2016YFD0401404),

372

and Northern Jiangsu province science and technology projects (BN2016137), the

373

Fundamental Research Funds for the Central Universities (JUSRP51501).

374

Notes

375

The authors declare no competing financial interest.

376

REFERENCES

Tel:

+86-0510-85876799;

Fax:

+86-0510-85876799;

17


E-mail:


377

(1) Homma, R.; Suzuki, K.; Cui, L., Mcclements, D. J.; Decker, E. A. Impact of

378

association colloids on lipid oxidation in triacylglycerols and fatty acid ethyl esters.

379

J. Agric. Food Chem. 2015, 63, 10161–10169.

380

(2) Shahidi, F.; Zhong, Y. Lipid oxidation and improving the oxidative stability.

381

Chem. Soc. Rev. 2010, 39, 4067–4079.

382

(3) Barden, L.; Decker, E. A. Lipid oxidation in low-moisture food: a review. Crit.

383

Rev. Food Sci. 2016, 63, 1812–1818.

384

(4) Kanner, J. Dietary advanced lipid oxidation endproducts are risk factors to

385

human health. Mol. Nutr. Food Res. 2007, 51, 1094–1101.

386

(5) Mozaffarian, D. Trans fatty acids-Effects on systemic inflammation and

387

endothelial function. Atherosclerosis Supp. 2006, 7, 29–32.

388

(6) Erickson, M. D. Production and Composition of Frying Fats. In Deep Frying:

389

Chemistry, Nutrition, and Practical Applications; Erickson, M. D., Eds. 2nd; AOCS

390

Press: Urbana, IL, USA, 2006; pp 3–24.

391

(7) Zhang, Q.; Saleh, A. S. M.; Chen, J.; Shen, Q. Chemical alterations taken place

392

during deep-fat frying based on certain reaction products: a review. Chem. Phys

393

lipids 2012, 165, 662-681.

394

(8) Kmiecik, D.; Kobus-Cisowska, J.; Korczak, J. The content of anti-nutritional

395

components in frozen fried-potato products. LWT - Food Sci. Tech. Nol. 2017, 85,

396

275–282.

397

(9) Frankel, E. N. Production and Composition of Frying Fats. In Lipid Oxidation;

398

Frankel, E. N., Eds. 2nd; The Oily Press: Davis, CA, USA, 2005; Vol. 18, pp 25–38. 18


Page 18 of 34

Page 19 of 34


399

(10) Fukushima, A.; Hayakawa, M.; Sugiyama, S.; Ajioka, M.; Ito, T.; Satake, T.;

400

Ozawa, T. Cardiovascular effects of leukotoxin (9,10-epoxy-12-octadecenoate) and

401

free fatty acids in dogs. Cardiovasc. Res. 1988, 22, 213–218.

402

(11) Greene, J. F.; Newman, J. W.; Williamson, K. C.; Hammock, B. D. Toxicity of

403

epoxy fatty acids and related compounds to cells expressing human soluble epoxide

404

hydrolase. Chem. Res. Toxicol. 2000, 13, 217–226.

405

(12) Wilson, R.; Fernie, C. E.; Scrimgeour, C. M.; Lyall, K.; Smyth, L.; Riemersma,

406

R. A. Dietary epoxy fatty acids are absorbed in healthy women. Eur. J. Clin. Invest.

407

2002, 32, 79–83.

408

(13) Marmesat, S.; Velasco, J.; Dobarganes, M. C. Quantitative determination of

409

epoxy acids, keto acids and hydroxy acids formed in fats and oils at frying

410

temperatures. J. Chromatogr. A 2008, 1211, 129–134.

411

(14) Mubiru, E.; Shrestha, K.; Papastergiadis, A.; De Meulenaer, B. Development

412

and validation of a gas chromatography–flame ionization detection method for the

413

determination of epoxy fatty acids in food matrices. J. Agric. Food Chem. 2014, 62,

414

2982–2988.

415

(15) Velasco, J.; Marmesat, S.; Bordeaux, O.; Márquez-Ruiz, G.; Dobarganes, C.

416

Formation and evolution of monoepoxy fatty acids in thermoxidized olive and

417

sunflower oils and quantitation in used frying oils from restaurants and fried-food

418

outlets. J. Agric. Food Chem. 2004, 52, 4438–4443.

19



419

(16) Liu, Y.; Wang, Y.; Cao, P.; Liu, Y. Quantitative determination of epoxy stearic

420

acids derived from oxidized frying oil based on solid-phase extraction and gas

421

chromatography. LWT-Food Sci. Tech. Nol. 2018, 92, 250–257.

422

(17) Hu, J. N.; Taki, F.; Sugiyama, S.; Asai, J.; Izawa, Y.; Satake, T.; Ozawa, T.

423

Neutrophil-derived epoxide, 9,10-epoxy-12-octadecenoate, induces pulmonary

424

edema. Lung. 1988, 166, 327-337.

425

(18) Liu, R.; Jin, Q.; Huang, J.; Liu, Y.; Wang, X.; Zhou, X., Mao, W; Wang, S. In

426

vitro toxicity of aflatoxin b1 and its photodegradation products in hepg2 cells. J.

427

Appl. Toxicol. 2012, 32, 276–281.

428

(19) Iizaka, T.; Tsuji, M.; Oyamada, H.; Morio, Y.; Oguchi, K. Interaction between

429

caspase-8 activation and endoplasmic reticulum stress in glycochenodeoxycholic

430

acid-induced apoptotic hepg2 cells. Toxicology 2007, 241, 146–156.

431

(20) Yeh, C. T.; Yen, G. C. Involvement of p38 MAPK and Nrf2 in phenolic

432

acid-induced P-form phenol sulfotransferase expression in human hepatoma HepG2

433

cells. Carcinogenesis 2006, 27, 1008–1017.

434

(21) Lin, Y.; Vermeer, M. A.; Bos, W.; Van, B. L.; Schuurbiers, E.; Miretcatalan, S.;

435

Trautwein, E. A. Molecular structures of citrus flavonoids determine their effects on

436

lipid metabolism in HepG2 cells by primarily suppressing ApoB secretion. J. Agric.

437

Food Chem. 2011, 59, 4496–4503.

438

(22) Tu, Z.; Mosspierce, T.; Ford, P.; Jiang, A. Rosemary (Rosmarinus officinalis L.)

439

extract regulates glucose and lipid metabolism by activating AMPK and PPAR

440

pathways in HepG2 cells. J. Agric. Food Chem. 2013, 61, 2803–2810. 20


Page 20 of 34

Page 21 of 34


441

(23) Wang, C.; Wang, L.; Li, W.; Yan, F.; Tian, M.; Wu, C.; Qi, L.; Wang, X.; Song,

442

J.; Hou, X.; Chen, L. Irisin has no effect on lipolysis in 3T3-L1 adipocytes or fatty

443

acid metabolism in HepG2 hepatocytes. Endocrine 2015, 49, 90–96.

444

(24) Feldstein, A. E.; Lopez, R.; Tamimi, T. A.; Yerian, L.; Chung, Y. M.; Berk, M.;

445

Zhang, R.; Mclntyre, T. M.; Hazen, S. L. Mass spectrometric profiling of oxidized

446

lipid products in human nonalcoholic fatty liver disease and nonalcoholic

447

steatohepatitis. J. Lipid. Res. 2010, 51, 3046–3054.

448

(25)

449

Inflammation-related gene expression by lipid oxidation-derived products in the

450

progression of atherosclerosis. Free. Radical. Bio. Med. 2012, 52, 19–34.

451

(26) Poli, G.; Sottero, B.; Gargiulo, S.; Leonarduzzi, G. Cholesterol oxidation

452

products in the vascular remodeling due to atherosclerosis. Mol. Aspects. Med. 2009,

453

30, 180–189.

454

(27) Horie, K.; Miyata, T.; Maeda, K.; Miyata, S.; Sugiyama, S.; Sakai, H.; Strihou,

455

C. Y.; Monnier, V. M.; Witztum, J. L.; Kurokawa, K. Immunohistochemical

456

colocalization of glycoxidation products and lipid peroxidation products in diabetic

457

renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of

458

diabetic nephropathy. J. Clin. Invest. 1997, 100, 2995–3004.

459

(28) Li, J.; Li, X.; Cai, W.; Liu, Y. Comparison of different polar

460

compounds-induced cytotoxicity in human hepatocellular carcinoma HepG2 cells.

461

Lipids. Health. Dis. 2016, 15, 30–35.

Leonarduzzi,

G.;

Gamba,

P.;

Gargiulo,

S.;

21


Biasi,

F.;

Poli,

G.


462

(29) Dhibi, M.; Brahmi, F.; Mnari, A.; Houas, Z.; Chargui, I.; Bchir, L.; Gazzah, N.;

463

Alsaif, M. A.; Hammami, M. The intake of high fat diet with different trans fatty

464

acid levels differentially induces oxidative stress and non alcoholic fatty liver disease

465

(NAFLD) in rats. Nutrition & Metabolism, 2011, 8, 65–76.

466

(30) Demozay, D.; Mas, J. C.; Rocchi, S.; Van, O. E. Faldh reverses the deleterious

467

action of oxidative stress induced by lipid peroxidation product 4-hydroxynonenal

468

on insulin signaling in 3T3-L1 adipocytes. Diabetes 2008, 57, 1216–1226.

469

(31) Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and

470

functional foods: impact on human health. Pharmacogn. Mag. 2010, 4, 118–126.

471

(32) Greene, J. F.; Newman, J. W.; Williamson, K. C.; Hammock, B. D. Toxicity of

472

epoxy fatty acids and related compounds to cells expressing human soluble epoxide

473

hydrolase. Chem. Res. Toxicol. 2000, 13, 217–226.

474

(33) Cao, W.; Wang, X.; Zhang, W.; Xingguo Wang. Toxic effects of triacylglycerol

475

polymer on macrophages in vitro. Eur. J. Lipid. Sci. Tech. 2013, 115, 756–763.

476

(34) Stemmer, U.; Dunai, Z. A.; Koller, D.; Pürstinger, G.; Zenzmaier, E.; Deigner,

477

H. P.; Aflaki, E.; Kratky, D.; Hermetter, A. Toxicity of oxidized phospholipids in

478

cultured macrophages. Lipids. Health Dis. 2012, 11, 1–13.

479

(35) Ozawa, T.; Sugiyama, S.; Hayakawa, M.; Satake, T.; Taki, F.; Iwata, M.; Taki, K.

480

Existence of leukotoxin 9,10-epoxy-12-octadecenoate in lung lavages from rats

481

breathing pure oxygen and from patients with the adult respiratory distress syndrome.

482

Am. Rev. Respir. Dis. 1988, 137, 535-540.

22


Page 22 of 34

Page 23 of 34


483

(36) Zhang, X.; Wang, L.; Wang, R.; Luo, X.; Li, Y.; Chen, Z. Protective effects of

484

rice dreg protein hydrolysates against hydrogen peroxide-induced oxidative stress in

485

HepG-2 cells. Food. Funct. 2016, 7, 1429–1437.

486

(37) Nordberg, J.; Arnér, E. S. J. Reactive oxygen species, antioxidants, and the

487

mammalian thioredoxin system 1. Free. Radical. Bio. Med. 2001, 31, 1287–1312.

488

(38) Ceconi, C.; Boraso, A.; Cargnoni, A.; Ferrari, R. Oxidative stress in

489

cardiovascular disease: myth or fact? Arch. Biochem. Biophys. 2003, 420, 217–221.

490

(39) Sohal, R.; Mockett, R.; Orr, W. Mechanisms of aging: an appraisal of the

491

oxidative stress hypothesis. Free. Radical. Bio. Med. 2002, 33, 575–586.

492

(40) Adly, A. A. M. Oxidative stress and disease: an updated review. Res. J.

493

Immunol. 2010, 3, 129–145.

494

(41) Del, R. D.; Stewart, A. J.; Pellegrini, N. A review of recent studies on

495

malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr.

496

Metab. Cardiovas. 2005, 15, 316–328.

497

(42) Chow, C. K. Biological effects of oxidized fatty acids. In Fatty acids in foods and

498

their health implications, 3rd ed.; Chow, C. K., Eds. 3rd; CRC Press, Taylor and

499

Francis Book: Boca Raton, FL, 2008; pp 855–878.

500

(43) Kangralkar, V.A.; Patil, S. D.; Bandivadekar, R. M. Oxidative stress and

501

diabetes: A review. Int. J. Pharm. Appl. 2010, 1, 38–45.

502

(44) Bhor, V. M.; Raghuram, N.; Sivakami, S. Oxidative damage and altered

503

antioxidant enzyme activities in the small intestine of streptozotocin-induced

504

diabetic rats. Int. J. Biochem. Cell. B. 2004, 36, 89–97. 23



505

(45) Halliwell, B.; Gutteridge, J. M. C. Free radicals and antioxidant protection:

506

mechanisms and significance in toxicology and disease. Hum. Toxicol. 1988, 7, 7–

507

13.

508

FIGURE CAPTIONS

509

Figure 1

510

Structure formulas of formation of epoxy stearic acid derived from oleic acid during

511

thermal oxidation.

512

Figure 2

513

Effects of OA and ESA on the viability of HepG2 cells. Different lowercase letters in

514

the same column indicate significant differences (P < 0.05) for the same sample.

515

Figure 3

516

Effects of OA (A) and ESA (B) on the cell cycle arrest of HepG2 cells.

517

Figure 4

518

Flow cytometric analysis for apoptosis induction of HepG2 cells treated with OA

519

and ESA.

520

Figure 5

521

Effect of OA and ESA on the intracellular ROS level of HepG2 cells.

522

Figure 6

523

Effect of OA and ESA on the intracellular MDA (A) level and activity of antioxidant

524

enzymes including SOD (B), CAT (C) and GSH-Px (D) of HepG2 cells.

24


Page 24 of 34

Page 25 of 34


Figure 1. Structure formulas of formation of epoxy stearic acid derived from oleic acid during thermal oxidation.

25



100

a

a b

Cell viability (%)

c a a

d e

d e e

25

ESA

10 20 50 100 200 500 12 h

d d

c c

b

c f

0

e

c

c b

c

b b

d d

b

50

a

a b

a 75

Page 26 of 34

10 20 50 100 200 500 24 h

c d d d

10 20 50 100 200 500

OA

48 h

10 20 50 100 200 500

10 20 50 100 200 500

10 20 50 100 200 500

12 h

24 h

48 h

Concentration of ESA and OA (µM)

Figure 2. Effects of OA and ESA on the viability of HepG2 cells. Different lowercase letters in the same column indicate significant differences (P < 0.05) for the same sample.

26


Page 27 of 34


S

G0/G1

G2/M

Cell cycle distribution (%)

(A) 100

75

50

25

0 0

10

20

50 100 200 500 12 h

50 100 200 500 24 h Concentration of OA (µM)

0

10

20

S

G0/G1

0

10

20

50 100 200 500 48 h

0

10

20

50 100 200 500 48 h

G2/M

Cell cycle distribution (%)

(B) 100

75

50

25

0 0

10

20

50 100 200 500 12 h

0

10

20

50 100 200 500 24 h

Concentration of ESA (µM)

Figure 3. Effects of OA (A) and ESA (B) on the cell cycle arrest of HepG2 cells.

27



Page 28 of 34

12 h

OA

ESA

24 h

OA

ESA

48 h

OA

ESA

28

Control

10

20

50

100

Concentration of OA and ESA (µM) ACS Paragon Plus Environment

200

500

Page 29 of 34


Figure 4. Flow cytometric analysis for apoptosis induction of HepG2 cells treated with OA and ESA.

29



Page 30 of 34

12 h

OA

ESA

24 h

OA

ESA

48 h

OA

(A) ESA

30

Control

10

20

50

100

Concentration of OA and ESA (µM) ACS Paragon Plus Environment

200

500

Page 31 of 34


(B) 350 300

Relative levels of ROS (%)

c

c

250

c

e

d

e

e

d

f b

e d

b

Control OA ESA

f

f

d g

200 b

e 150 a

b

b

b

c

f

c c

a aa

100

e

d

c

b

d

d

e

f

b

50 0

Con 10

20

50 100 200 500 12 h

Con 10 20

50 100 200 500 24 h

Con 10 20

50 100 200 500 48 h

Concentration of OA and ESA (µM)

Figure 5. Effect of OA and ESA on the intracellular ROS level of HepG2 cells.

31



(A) 10

Control OA ESA

g

8

MDA (nmol/mg protein)

Page 32 of 34

f e

f 6 d

e d

4

c c

b bc a ab Con 10

20

f

d de

cd

e

g

b

e

2

0

g f

d

ab

50 100 200 500 12 h

e

d

c

Con 10 20

50 100 200 500 24 h

g e

d

c

ab

d

c

b

Con 10 20

f

50 100 200 500 48 h


(B) 2.0

SOD (U/mg protein)

1.5

Control OA ESA a b b bc

a c

b

d d e

1.0

e

e

c

f b

g

c

d

d

e

c d

a b

e f

0.5

b c

g

c

d d

e

g

f e

g

f 0.0

Con 10

20

50 100 200 500 12 h

Con 10 20

50 100 200 500 24 h

Con 10 20

50 100 200 500 48 h


(C) 120 a ab

b

c

b c

CAT (U/mg protein)

90

aa

c d d

Control OA ESA

c

b

d d

e e

f

e

b

a

g

b c

60

d

e

c b

f

c

d

d 30

0

Con 10

20

50 100 200 500 12 h

Con 10 20

f

e

g

g

50 100 200 500 24 h

Con 10 20


32


e

f

g

50 100 200 500 48 h

Page 33 of 34


(D) 150

GSH-Px (mU/mg protein)

125

100

a b

Control OA ESA

a c b

b c d d

75

c

e

a

e e

f

b

f g

b

d

bd c

e c

f

c b

d

c d

e

e d

50

f

g

e f

g

25

0

Con 10

20

50 100 200 500 12 h

Con 10 20

50 100 200 500 24 h

Con 10 20

50 100 200 500 48 h


Figure 6. Effect of OA and ESA on the intracellular MDA (A) level and activity of antioxidant enzymes including SOD (B), CAT (C) and GSH-Px (D) of HepG2 cells.

33



GRAPHIC FOR TABLE OF CONTENTS

34


Page 34 of 34

Epoxy stearic acid, an oxidative product derived from oleic acid

Recommend Documents